Cargando…

Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis

BACKGROUND AND OBJECTIVES: Five-tumour necrosis factor (TNF)-blockers (infliximab, etanercept, adalimumab, certolizumab pegol and golimumab) are available for treatment of rheumatoid arthritis. Only few clinical trials compare one TNF-blocker to another. Hence, a systematic review is required to ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aaltonen, Kalle J., Virkki, Liisa M., Malmivaara, Antti, Konttinen, Yrjö T., Nordström, Dan C., Blom, Marja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260264/ https://www.ncbi.nlm.nih.gov/pubmed/22272322 http://dx.doi.org/10.1371/journal.pone.0030275

Ejemplares similares

The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review
por: Joensuu, Jaana T., et al.
Publicado: (2015)

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis
por: Huoponen, Saara, et al.
Publicado: (2019)

Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach: A systematic review of the literature
por: Jämsen, Esa, et al.
Publicado: (2009)

Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis
por: Benucci, M, et al.
Publicado: (2012)

Circadian Timekeeping Is Disturbed in Rheumatoid Arthritis at Molecular Level
por: Kouri, Vesa-Petteri, et al.
Publicado: (2013)

TCD4(pos) lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents
por: Picchianti Diamanti, Andrea, et al.
Publicado: (2017)

Differentially Expressed in Chondrocytes 2 (DEC2) Increases the Expression of IL-1β and Is Abundantly Present in Synovial Membrane in Rheumatoid Arthritis
por: Olkkonen, Juri, et al.
Publicado: (2015)

Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis
por: Barreto, Goncalo, et al.
Publicado: (2015)

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis
por: Zhou, Mengshi, et al.
Publicado: (2020)

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
por: Fragoulakis, Vasilis, et al.
Publicado: (2015)

Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis
por: Toonen, Erik J. M., et al.
Publicado: (2012)

Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
por: Schwartzman, Sergio, et al.
Publicado: (2004)

Impact of TNF inhibitor medication on working ability in axial spondyloarthritis: an observational national registry-based cohort study
por: Hokkanen, Anna-Mari, et al.
Publicado: (2023)

Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany
por: Neubauer, Sarah, et al.
Publicado: (2014)

How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers
por: Chatzidionysiou, Katerina, et al.
Publicado: (2020)

Load-Bearing Biomedical Applications of Diamond-Like Carbon Coatings - Current Status
por: Alakoski, Esa, et al.
Publicado: (2008)

Bone and TNF in rheumatoid arthritis: clinical implications
por: Manara, Maria, et al.
Publicado: (2015)

Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2016)

Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
por: Flendrie, Marcel, et al.
Publicado: (2005)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
por: Al-Rayes, Hannan, et al.
Publicado: (2011)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
por: Vial, Gaelle, et al.
Publicado: (2021)

Fibroblast biology: Signals targeting the synovial fibroblast in arthritis
por: Konttinen, Yrjö T, et al.
Publicado: (2000)

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis
por: Iwaszko, Milena, et al.
Publicado: (2018)

Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis
por: Ursini, Francesco, et al.
Publicado: (2017)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
por: Said, Cynthia, et al.
Publicado: (2013)

Dopaminergic Agents in Rheumatoid Arthritis
por: Capellino, Silvia
Publicado: (2019)

Rheumatoid arthritis is associated with increased DKK1 expression and disturbances in the bone turnover regulating genes
por: Caetano-Lopes, Joana, et al.
Publicado: (2011)

Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic Diseases
por: Takakubo, Yuya, et al.
Publicado: (2012)

Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
por: Tynjälä, P, et al.
Publicado: (2008)

Toll-like receptors in human chondrocytes and osteoarthritic cartilage
por: Sillat, Tarvo, et al.
Publicado: (2013)

Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results
por: Süha, Çetin, et al.
Publicado: (2014)

New approaches to inhibiting TNF production in rheumatoid arthritis: is pathological TNF regulated in the same way as protective TNF?
por: Feldmann, M, et al.
Publicado: (2001)

Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis
por: Corrado, Addolorata, et al.
Publicado: (2017)

Metabolic Effects of Anti-TNF-α Treatment in Rheumatoid Arthritis
por: Macáková, Kristína, et al.
Publicado: (2023)

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
por: Finckh, A, et al.
Publicado: (2010)

No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
por: Li, Xuefei, et al.
Publicado: (2023)

REGENERATIVE MEDICINE – INITIATIVE À LA CARTE A remedy to the blood thirsty count Dracula?
por: Konttinen, Yrjö T, et al.
Publicado: (2008)

Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF–TNF-RII binding in rheumatoid arthritis
por: Nguyen, Dao Xuan, et al.
Publicado: (2016)

The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy: A nationwide register-based study from 1995 through 2010
por: Jämsen, Esa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_okbo9vc9u8lq48gf69akpkqs19